U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C18H17ClN2O.ClH
Molecular Weight 349.254
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLAZOLAM HYDROCHLORIDE

SMILES

Cl.CN1C2=CC=C(Cl)C=C2C3N(CCC4=C3C=CC=C4)CC1=O

InChI

InChIKey=QUKBWEQECNCFCF-UHFFFAOYSA-N
InChI=1S/C18H17ClN2O.ClH/c1-20-16-7-6-13(19)10-15(16)18-14-5-3-2-4-12(14)8-9-21(18)11-17(20)22;/h2-7,10,18H,8-9,11H2,1H3;1H

HIDE SMILES / InChI

Description

Clazolam (isoquinazepon) is a fuzed benzodiazepine drug developed by Sandoz in the 1960s. The drug is claimed to have anxiolytic properties, which are manifested in a reduction of cramping, antagonism of amphetamine, and by inhibition of spinal reflexes.

Approval Year

Unknown
149124
Name Type Language
CLAZOLAM HYDROCHLORIDE
Common Name English
ISOQUINO(2,1-D)(1,4)BENZODIAZEPIN-6(7H)-ONE, 2-CHLORO-5,9,10,14B-TETRAHYDRO-5-METHYL-, MONOHYDROCHLORIDE
Preferred Name English
ISOQUINO(2,1-D)-1,4-BENZODIAZEPIN-2(3H)-ONE, 12-CHLORO-1,5,6,10B-TETRAHYDRO-1-METHYL-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
FDA UNII
X1I6TB3OBS
Created by admin on Mon Mar 31 21:15:07 GMT 2025 , Edited by admin on Mon Mar 31 21:15:07 GMT 2025
PRIMARY
CAS
23193-67-1
Created by admin on Mon Mar 31 21:15:07 GMT 2025 , Edited by admin on Mon Mar 31 21:15:07 GMT 2025
PRIMARY
CAS
14803-15-7
Created by admin on Mon Mar 31 21:15:07 GMT 2025 , Edited by admin on Mon Mar 31 21:15:07 GMT 2025
NON-SPECIFIC STOICHIOMETRY
ACTIVE MOIETY
Structure of CLAZOLAM
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966